COMPANY
Fina Biosolutions
NIH awards 2
- NIH award 1R43AI181078-01 FY2024: $297,809 awarded for that fiscal year; activity R43 (SBIR); PI LEES, ANDREW; recipient as written: FINA BIOSOLUTIONS, LLC, ROCKVILLE, MD. E. coli platform for expression of low-cost source ↗
- NIH award 1R43AI148018-01A1 FY2020: $289,089 awarded for that fiscal year; activity R43 (SBIR); PI LEES, ANDREW; recipient as written: FINA BIOSOLUTIONS, LLC, ROCKVILLE, MD. Genetically detoxified tetanus toxin for u source ↗